BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

O.C. Heart Device Firm, Cameron Health Raises $107 Million


5/19/2011 9:15:26 AM

San Clemente-based medical device maker Cameron Health Inc. has raised $107 million in venture funding, one of the larger financing rounds a company based here has seen.

Cameron, which makes an implantable heart defibrillator, raised the money in a round led by Palo Alto’s Alloy Ventures and Delphi Ventures of Menlo Park.

The company now has raised nearly $200 million in financing.

Cameron plans to use the latest money to push sales of its device in Europe and other global markets and for an upcoming U.S. clinical trial.

The company plans to enroll patients for a U.S. trial this year. It’s targeting the third quarter to submit data to the Food and Drug Administration and a possible approval in late 2012.

Cameron’s defibrillator is implanted under the skin and provides an electric shock to interrupt a potentially fatal heart rhythm during a heart attack.

The company is on the radar of big medical device makers, including Natick, Mass.-based Boston Scientific Corp.—a Cameron investor that has the right to buy the company—as well as St. Jude Medical Inc. of St. Paul, Minn., and Minneapolis-based Medtronic Inc.

Cameron could seek to do initial public offering or sell to another company if Boston Scientific passes on its option to acquire the company.

For more on Cameron, see a prior Business Journal story.

The funding round is one of the biggest seen here.

Earlier this month, Anaheim hybrid auto developer Fisker Automotive Inc. raised $100 million, bringing its total raised to $1 billion in investor and government financing.



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->